Security key
75943R102
Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)
CUSIP: 75943R102
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 4,389,099
- Total 13F shares
- 131,039,866
- Share change
- +3,028,199
- Total reported value
- $2,156,444,291
- Put/Call ratio
- 81%
- Price per share
- $16.47
- Number of holders
- 155
- Value change
- +$53,163,179
- Number of buys
- 74
- Number of sells
- 82
Report period
Q1 2023
Institutions
155
Top holders
10
RLAY full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Relay Therapeutics, Inc. SEC filings
Relay Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75943R102
Recent filing periods:
Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
636%
|
27,904,963
|
$416,900,147 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
237%
|
10,384,218
|
$155,140,217 | — | 31 Dec 2022 | |
| FMR LLC |
13F
|
Company |
222%
|
9,733,848
|
$145,423,690 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
182%
|
7,997,985
|
$119,489,896 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
143%
|
6,264,497
|
$93,591,585 | — | 31 Dec 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
102%
|
4,493,004
|
$67,126,000 | — | 31 Dec 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
102%
|
4,469,898
|
$66,780,000 | — | 31 Dec 2022 | |
| Bellevue Group AG |
13F
|
Company |
96%
|
4,204,820
|
$62,820,011 | — | 31 Dec 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
95%
|
4,163,824
|
$62,207,531 | — | 31 Dec 2022 | |
| BVF INC/IL |
13F
|
Company |
88%
|
3,876,021
|
$57,907,754 | — | 31 Dec 2022 | |
| Casdin Capital, LLC |
13F
|
Company |
69%
|
3,030,648
|
$45,277,881 | — | 31 Dec 2022 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
61%
|
2,686,711
|
$40,139,462 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
54%
|
2,369,344
|
$35,397,999 | — | 31 Dec 2022 | |
| Boxer Capital, LLC |
13F
|
Company |
49%
|
2,169,132
|
$32,406,832 | — | 31 Dec 2022 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
46%
|
2,006,541
|
$29,978,000 | — | 31 Dec 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
44%
|
1,943,097
|
$29,029,869 | — | 31 Dec 2022 | |
| NORGES BANK |
13F
|
Company |
41%
|
1,788,323
|
$26,717,546 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
39%
|
1,694,121
|
$25,310,000 | — | 31 Dec 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
39%
|
1,690,021
|
$25,248,914 | — | 31 Dec 2022 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
37%
|
1,618,353
|
$24,178,194 | — | 31 Dec 2022 | |
| Alphabet Inc. |
13F
|
Company |
36%
|
1,568,753
|
$23,437,170 | — | 31 Dec 2022 | |
| Artal Group S.A. |
13F
|
Company |
33%
|
1,454,716
|
$21,733,000 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
29%
|
1,273,415
|
$19,024,821 | — | 31 Dec 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
28%
|
1,238,872
|
$18,507,880 | — | 31 Dec 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
24%
|
1,058,543
|
$15,814,000 | — | 31 Dec 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
24%
|
1,051,425
|
$15,708,289 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
20%
|
882,295
|
$13,181,488 | — | 31 Dec 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
19%
|
815,998
|
$12,191,010 | — | 31 Dec 2022 | |
| Finepoint Capital LP |
13F
|
Company |
16%
|
714,848
|
$10,680,000 | — | 31 Dec 2022 | |
| Rock Springs Capital Management LP |
13F
|
Company |
15%
|
673,966
|
$10,069,052 | — | 31 Dec 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
15%
|
654,443
|
$9,777,378 | — | 31 Dec 2022 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
14%
|
625,000
|
$9,337,500 | — | 31 Dec 2022 | |
| BESSEMER GROUP INC |
13F
|
Company |
13%
|
584,463
|
$8,732,000 | — | 31 Dec 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
13%
|
575,136
|
$8,593,000 | — | 31 Dec 2022 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
12%
|
541,124
|
$8,084,393 | — | 31 Dec 2022 | |
| Nextech Invest Ltd. |
13F
|
Company |
11%
|
475,485
|
$7,103,746 | — | 31 Dec 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
11%
|
474,279
|
$7,085,728 | — | 31 Dec 2022 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
9.4%
|
414,522
|
$6,192,958 | — | 31 Dec 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
8.9%
|
388,485
|
$5,803,966 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
8.1%
|
354,489
|
$5,296,066 | — | 31 Dec 2022 | |
| Woodline Partners LP |
13F
|
Company |
7.6%
|
331,663
|
$4,955,045 | — | 31 Dec 2022 | |
| Sessa Capital IM, L.P. |
13F
|
Company |
6.9%
|
301,200
|
$4,499,928 | — | 31 Dec 2022 | |
| HARBOURVEST PARTNERS LLC |
13F
|
Company |
6.8%
|
296,402
|
$4,428,246 | — | 31 Dec 2022 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
6.7%
|
295,454
|
$4,414,083 | — | 31 Dec 2022 | |
| Ghisallo Capital Management LLC |
13F
|
Company |
6.3%
|
274,773
|
$4,105,109 | — | 31 Dec 2022 | |
| BARCLAYS PLC |
13F
|
Company |
6.2%
|
271,839
|
$4,061,274 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
6%
|
263,100
|
$3,930,714 | — | 31 Dec 2022 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
5.4%
|
238,242
|
$3,559,335 | — | 31 Dec 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
5.4%
|
236,964
|
$3,540,242 | — | 31 Dec 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
5.4%
|
235,203
|
$3,514,000 | — | 31 Dec 2022 |
Institutional Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY) as of Q1 2023
As of 31 Mar 2023,
Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY) was held by
155 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
131,039,866 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Casdin Capital, LLC, JPMORGAN CHASE & CO, Bellevue Group AG, and EcoR1 Capital, LLC.
This page lists
155
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
163
Q1 2023 holders
155
Holder diff
-8
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.